In cancer samples or cell lines, TYK2 was found to cooperate with other oncogenic effectors and pathways, such as the RAF/ERK [53,55,61], MAPKs [135], PIM1/2 [84], and PI3K/AKT/mTOR pathway [36,53,61]. Here, TYK2 is linked to cancer.